快速部署主动脉瓣置换术:优异结果与有效瓣口面积增加
本研究比较快速部署主动脉瓣置换术(RDAVR)与标准主动脉瓣置换术(AVR)的手术结果和血流动力学,采用倾向性匹配分析163对患者。RDAVR组主动脉阻断和体外循环时间显著缩短,植入瓣膜更大,跨瓣压差更低,有效瓣口面积更高,但RDAVR联合CABG组术后起搏器植入率较高。
要点
- RDAVR缩短主动脉阻断和体外循环时间,尤其在联合手术中。
- RDAVR允许使用更大尺寸瓣膜,降低跨瓣压差,提高有效瓣口面积。
- RDAVR联合CABG时术后起搏器植入率较高,需关注。
核心结论
- RDAVR相比标准AVR缩短主动脉阻断和体外循环时间,尤其在同合并手术患者中,允许使用更大尺寸瓣膜,降低跨瓣压差并提高 indexed effective orifice area(有效瓣口面积指数),可能有助于克服患者-人工瓣膜不匹配。
研究设计与样本
- 回顾性倾向性匹配研究,比较163例RDAVR患者(孤立手术67例,联合CABG 96例)与163例标准AVR对照。
主要发现
- RDAVR组主动脉阻断和体外循环时间分别为55±23分钟和88±38分钟,对照组为77±22分钟和105±38分钟(p<0.001)。
- 孤立RDAVR亚组主动脉阻断和体外循环时间分别为38±13分钟和66±22分钟,对照组为55±14分钟和81±18分钟(p<0.001)。
- RDAVR组植入瓣膜尺寸为23.3±1.8 mm,大于对照组的22.8±1.5 mm(p=0.002)。
- RDAVR组平均跨瓣压差和 indexed effective orifice area 分别为9±5 mm Hg和1.11±0.11,对照组为13±5 mm Hg和0.95±0.08(p<0.001)。
- 院内死亡率两组相似(1.8%,3/163;p=1.000);孤立RDAVR起搏器植入率3.5%(3/67) vs 孤立AVR 3.0%(2/67;p=0.649);RDAVR/CABG起搏器植入率12.5%(12/96) vs AVR/CABG 4.2%(4/96;p=0.032)。
临床怎么用
- 对于需行主动脉瓣置换的患者,尤其合并CABG时,RDAVR可缩短手术时间并改善血流动力学。
- 选择RDAVR时需权衡起搏器植入风险,特别是在联合CABG的患者中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to evaluate the effects of rapid deployment aortic valve replacement (RDAVR) on surgical outcome and hemodynamics compared with standard aortic valve replacement (AVR). METHODS: One hundred sixty-three RDAVR patients (isolated, n = 67; combined with coronary artery bypass graft surgery [CABG], n = 96) were compared with a propensity matched control group (n = 163). Primary endpoints included association between valve type and procedure times, prosthesis size, transvalvular gradient, and indexed effective orifice area. Secondary endpoints were postoperative mortality and morbidity. RESULTS: Aortic cross-clamp and cardiopulmonary bypass times in the RDAVR group were 55 ± 23 and 88 ± 38 minutes, respectively, compared with 77 ± 22 and 105 ± 38 minutes in the control group (p < 0.001). In the subgroup of patients undergoing isolated RDAVR (n = 67 of 163), the aortic cross-clamp and cardiopulmonary bypass times were 38 ± 13 and 66 ± 22 minutes, respectively, compared with 55 ± 14 and 81 ± 18 minutes in the control group (n = 67 of 163; p < 0.001). The RDAVR patients received larger prostheses (23.3 ± 1.8 mm) compared with standard AVR (22.8 ± 1.5 mm; p = 0.002). Mean transvalvular gradients and indexed effective orifice areas were 9 ± 5 mm Hg and 1.11 ± 0.11, respectively, in the RDVAR group compared with 13 ± 5 mm Hg and 0.95 ± 0.08 in the control group (p < 0.001). Hospital mortality was similar in both groups (1.8%, n = 3 of 163; p = 1.000). Postoperative pacemaker rates were 3.5% (n = 3 of 67) for isolated RDAVR versus 3.0% (n = 2 of 67; p = 0.649) for isolated AVR and 12.5% (n = 12 of 96) for RDAVR/CABG versus 4.2% (n = 4 of 96; p = 0.032) for AVR/CABG. CONCLUSIONS: RDAVR facilitates reduced aortic cross-clamp and cardiopulmonary bypass times compared with standard AVR, particularly in patients undergoing concomitant procedures, allowing the use of larger prostheses and resulting in lower transvalvular gradients and higher indexed effective orifice area compared with standard AVR. Therefore, RDAVR may help to overcome patient-prosthesis mismatch in some patients.
引用
- Rahmanian PB, Kaya S, Eghbalzadeh K, et al. Rapid Deployment Aortic Valve Replacement: Excellent Results and Increased Effective Orifice Areas. Ann Thorac Surg. 2017. PMID: 29132703. doi:10.1016/j.athoracsur.2017.07.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。